Funding helps ERC grant-holders to bridge the gap between their research and the earliest stage of a marketable innovation. The type of high-risk/high-gain research promoted by the ERC at the frontiers of knowledge often generates new or unexpected opportunities for commercial and societal applications.
The ERC is committed to ensuring the full exploitation of the outstanding ideas that it funds.
IRB Barcelona has been awarded 6 ERC-PoC projects.
BiomedTec is is an in-house programme supported by “la Caixa” Bank Foundation and devoted to validating early-stage technologies from all disciplines. The programme fosters the transfer of scientific results to the market, with the aim to improve patient quality of life.
The first call in 2012 was focused on cancer. Due to the success of this call, applications were broadened to all therapeutic fields, To date, this programme has launched 8 calls and has awarded funding to more than 20 projects in fields such as oncology, cardiometabolic , the central nervous system, ophthalmology, and trail-blazing research tools, among others.
The Knowledge Industry Programme, run by AGAUR (Agency for Management of University and Research Grants), a public funding body of the Government of Catalonia, fosters the transfer of technology and knowledge to the business sector. IRB Barcelona has been awarded funding in three project stage categories: Llavor (2), Producte (4), Mercat (1; project awarded to the spin-off Iproteos).
CaixaImpulse Validate is an acceleration programme promoted by “la Caixa" Foundation that provides support to early-stage biomedical research projects to help validate assets and define a valorisation plan. Apart from financing the valorisation plan, it strengthens the skills of future entrepreneurs. Three IRB Barcelona projects have benefited from this prestigious programme.
Gínjol is a new patent fund set up by CERCA, an organisation that belongs to the Government of Catalonia and that supervises, supports and facilitates the activities of research centres in Catalonia. IRB Barcelona received funding for projects submitted by Innovation Department in the first call for applications launched in 2016. To date, IRB Barcelona has been awarded 6 grants.
Doctorados Industriales, a call run by the Spanish Ministry for Science and Innovation, aims to promote PhD training in companies by co-financing the employment contracts of those undertaking doctoral studies. To favour the insertion of highly qualified staff into the business sector, PhD theses focus on industrial research or experimental development projects.
Promoted by the Botín Foundation, the “Mind the Gap” programme supports the development of products and services that arise from lab bench results. IRB Barcelona has been awarded three “Mind the Gap” projects, which have each received €500,000 , as well as specific support for two years.
The Technology Transfer Programme run by the Botín Foundation offers research groups financial and management resources with the aim to ensure the dynamic and effective transfer of knowledge to society and the productive sector. Five IRB Barcelona researchers have been invited to join this prestigious programme.
IRB Barcelona launches a scientific collaboration with Galapagos to identify and validate senolytic drug targets in inflammation and fibrosis
The AECC funds research into new treatment for prostate cancer
Alta Life Sciences leads an oversubscribed investment round into Inbiomotion to launch its diagnostic product in breast cancer
Launch of Gate2Brain, the “key” to transporting drugs into the brain and improving their effectiveness
Group: Gene Translation Laboratory
«One of the parameters for where I wanted to work was how easy it would be to start a spinoff, Barcelona—and the IRB— seemed to be a great place to go.»
Founder of Omnia Molecular
President of the Foundation of the National Institutes of Health and President of the IRB Barcelona Business Advisory Board
«Sometimes the best way to make research useful for society is to publish and bring new knowledge into public domain. In addition, we need to patend discoveries to guarantee their commercialization and provide incentives for pharmaceutical companies to develop drugs.»
«Inbiomotion is an example of how academic basic research can provide grounds to address an unmet medical need, making a step forward in the clinical standard of care using personalized medicine to prevent cancer metastasis.»
Founder of Inbiomotion
«Our Friedrich's Ataxia project is maginificent because it has come about from the patients. It reminds us that answers are provided by basic research, the cornerstone of all future applications.»
More on this news here.
«The innovation course has been one of the best experiences during my PhD at IRB Barcelona. It gave me insights into business development in the biotechnology sector, encouraging me to do science in a way that I found particularly attractive.»
«One of my goals when choosing IRB Barcelona was also to gain experience in tech transfer. I have ideas. And I want to learn how to convert them into a business.»
Mª Teresa Tarragó
Alumni - Research Associate
«If you have good knowledge of science and the skills to organise and lead a team, you can do other exciting and interesting things besides research.»
Co-founder of Iproteos.
Group: Colorectal Cancer Laboratory
«Our project, Colostage, aims to prevent patients who aren't at risk of developing metastasis from undergoing chemotherapy treatments which can be costly, unnecessary, and very aggressive. Our test will really help doctors chose the best choice of treatment for their patients. At the same time it will lead to substantial savings for the healthcare systems.»
More about this here.